Clostridium innocuum bacteremia secondary to infected hematoma with gas formation in a kidney transplant recipient

Transplant Infectious Disease

Volumn 5, Issue 4, 2003, Pages 199-202

  Castiglioni, B ^a   Gautam, A ^a   Citron, D M ^b   Pasculle, W ^a   Goldstein, E J C ^b   Strollo, Diane C ^a   Jordan, M ^a   Kusne, S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b R M ALDEN RESEARCH LABORATORY   (United States)

Author keywords

Clostridium innocuum; Gas forming infection; Hematoma; Kidney transplant

Indexed keywords

CEFOXITIN; CEPHALOSPORIN; CLINDAMYCIN; PENICILLIN G; QUINOLONE; VANCOMYCIN;

ABDOMEN; ADULT; ALLOGRAFT; ARTICLE; BACTEREMIA; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CASE REPORT; CLOSTRIDIUM; CLOSTRIDIUM INNOCUUM; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESISTANCE; DRUG SENSITIVITY; ETHNOLOGY; FEMALE; GAS; GAS GANGRENE; HEMATOMA; HEMODIALYSIS; HEPATITIS C; HUMAN; INCIDENCE; INTERSTITIAL NEPHRITIS; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT; ALLOTRANSPLANTATION; BACTERIAL INFECTION; ISOLATION AND PURIFICATION; REVIEW;

ADULT; BACTEREMIA; CLOSTRIDIUM; CLOSTRIDIUM INFECTIONS; FEMALE; HEMATOMA; HUMANS; KIDNEY TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 2342586627     PISSN: 13982273     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2003.00037.x     Document Type: Article

References (13)

1. ALLEN SD, EMERY CL, SIDERS JA. Clostridium. In: MURRAY PR, BARON EJ, PFALLER MA, et al., eds. Manual of Clinical Microbiology (7th edn.). Washington, DC: American Society for Microbiology, 1999: 654-671.
2. GORBACH SL, THADEPALLI H. Isolation of Clostridium in human infections: evaluation of 114 cases. J Infect Dis 1975; 131: 81-85.
3. CUTRONA AF, WATANAKUNAKORN C, SCHAUB CR, et al. Clostridium innocuum endocarditis. Clin Infect Dis 1995; 21: 1306-1307.
4. BODEY GP, RODRIGUEZ S, FAINSTEIN V, et al. Clostridial bacteremia in cancer patients. A 12-year experience. Cancer 1991; 67: 1928-1942.
5. ALPERN RJ, DOWELL VR. Nonhistotoxic clostridial bacteremia. Am J Clin Pathol 1971; 55: 117-122.
6. GORBACH SL, THADEPALLI H, NORSEN J. Anaerobic microorganisms in intraabdominal infections. In: BALOWS A, DEHAAN RM, DOWELL VR, et al., eds. Anaerobic Bacteria. Role in Disease. 1974: 399-407.
7. SUMMANEN P, BARON EJ, CITRON DM, et al. Wadsworth Anaerobic Bacteriology Manual. Belmont, CA: Star Publishing Company, 1993.
8. BROKAMP K, GREENE JN, SANDIN RL, et al. Clostridial bacteremia in a cancer hospital: a 6.5-year experience. Infect Med 1995; 12: 580, 587-591, 661.
9. FINEGOLD SM, BARON EJ, WELKER HM. A clinical guide to anaerobic infections. 1992: 52-53.
10. ALEXANDER CJ, CITRON DM, BRAZIER JS, et al. Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens. J Clin Microbiol 1995; 33: 3209-3215.
11. MORY F, LOZNIEWSKI A, DAVID V, et al. Low-level vancomycin resistance in Clostridium innocuum. J Clin Microbiol 1998; 36: 1767-1768.
12. CITRON DM, APPELBAUM PC. How far should a clinical laboratory go in identifying anaerobic isolates, and who should pay? Clin Infect Dis 1993; 16 (Suppl 4): S435-438.
13. GOLDSTEIN EJC, CITRON DM, WARREN Y, et al. In vitro activity of gemifloxacin (SB 265805) against anaerobes. Antimicrob Agents Chemother 1999; 43: 2231-2235.